V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 300006541 | 300006924 | null | null | Curative (C) | 2014-03-23 | 2014-04-21 | CARBOPLATIN | 02 | Y | 300017164 | CARBOPLATIN |
| 300006542 | 300007768 | null | 71.6 | Neo-adjuvant (N) | 2014-08-01 | 2014-09-01 | CISPLATIN + FLUOROURACIL | N | N | 300017179 | CAPECITABINE + OXALIPLATIN |
| 300006543 | 300004651 | 1.6 | 84 | Palliative (P) | 2016-05-10 | 2016-06-14 | Carboplatin + Cetux + FU (>Cycle 2) | 02 | N | 300017184 | CHOP R |
| 300006544 | 300004651 | 1.8 | 76.8 | Palliative (P) | 2017-01-26 | 2017-02-05 | Carboplatin AUC 2 - 5 | 02 | N | 300017184 | OXALIPLATIN + MDG |
| 300006545 | 300004652 | 1.84 | 94.15 | null | 2017-04-30 | 2017-04-30 | Trial Unspecified | N | N | 300017187 | CAPECITABINE + GEMCITABINE |
| 300006546 | 300004652 | null | null | Palliative (P) | 2015-09-16 | 2015-09-19 | CISPLATIN + FLUOROURACIL | Y | N | 300017187 | OXALIPLATIN + MDG |
| 300006547 | 300004652 | 1.92 | null | Palliative (P) | 2014-05-29 | 2014-06-03 | Cisplatin | 01 | N | 300017187 | BEVACIZUMAB |
| 300006548 | 300004652 | 1.57 | 60 | Curative (C) | 2016-11-05 | 2016-11-14 | CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB | null | N | 300017187 | CISPLATIN + FLUOROURACIL |
| 300006549 | 300004653 | 1.6 | 74.5 | Palliative (P) | 2016-03-19 | 2016-03-30 | Carboplatin + Vinorelbine Oral | N | N | 300017221 | CAPECITABINE + OXALIPLATIN |
| 300006550 | 300004654 | 1.6 | 91 | Neo-adjuvant (N) | 2016-10-19 | 2016-10-19 | Carboplatin AUC 2 - 5 | N | N | 300017222 | BEVACIZUMAB |
| 300006551 | 300004655 | 1.63 | 110 | Palliative (P) | 2014-06-24 | 2014-08-01 | GemCarbo Days 1+8 | 02 | N | 300017222 | CAPECITABINE |
| 300006552 | 300004655 | 1.71 | 56 | Curative (C) | 2016-10-25 | 2016-11-10 | Carboplatin AUC 6 - 10 | Y | Y | 300017222 | CETUXIMAB + RT |
| 300006553 | 300004656 | null | 62.2 | Neo-adjuvant (N) | 2014-01-04 | 2014-01-08 | CAPECITABINE + OXALIPLATIN | 02 | N | 300017241 | CYCLO + DOXORUBICIN + VINCRISTINE |
| 300006554 | 300006929 | 1.85 | 70 | Palliative (P) | 2013-09-17 | 2013-10-03 | NIVOLUMAB | N | N | 300017245 | OXALIPLATIN + MDG |
| 300006555 | 300004659 | 1.8 | 102.6 | Curative (C) | null | 2016-06-06 | MITOTANE | 2 | N | 300017256 | CAPECITABINE |
| 300006556 | 300004660 | 1.67 | 66 | Neo-adjuvant (N) | 2013-02-09 | 2013-03-16 | Cisplatin + Docetaxel +Fluorouracil | 1 | N | 300017262 | CISPLATIN |
| 300006557 | 300004661 | null | 63 | Neo-adjuvant (N) | 2015-04-10 | 2015-04-21 | CISPLATIN + FLUOROURACIL | N | null | 300017268 | CAPECITABINE + STREPTOZOCIN |
| 300006558 | 300004662 | 1.7 | 94.6 | Curative (C) | null | 2014-04-24 | Folfirinox | null | null | 300017270 | CETUXIMAB + RT |
| 300006561 | 300004664 | 1.71 | 62.9 | Palliative (P) | 2016-10-15 | 2016-10-15 | Carboplatin + Cetux + FU (Cycle 1) | N | N | 300017275 | CARBOPLATIN + PACLITAXEL |
| 300006562 | 300006931 | 1.62 | 59.9 | Neo-adjuvant (N) | 2015-01-14 | 2015-01-19 | Cisplatin +Fluorouracil (3 wk) | N | N | 300017279 | MELPHALAN |
| 300006563 | 300004666 | 1.72 | 55.2 | Curative (C) | 2017-11-08 | 2017-11-13 | Cetuximab 7 day (>Cycle 2) | N | Y | 300017280 | CETUXIMAB + RT |
| 300006564 | 300004667 | 1.65 | 69.2 | Palliative (P) | 2015-03-31 | 2016-10-15 | CISPLATIN + ETOPOSIDE + PACLITAXEL | 02 | N | 300017287 | CAPECITABINE + OXALIPLATIN |
| 300006565 | 300006932 | 1.6 | 74 | Neo-adjuvant (N) | 2013-09-05 | 2013-09-13 | Trial Unspecified | 02 | N | 300017287 | CARBOPLATIN + PACLITAXEL |
| 300006567 | 300004670 | 1.64 | 65.9 | Neo-adjuvant (N) | 2014-01-04 | 2014-03-12 | CARBOPLATIN + FLUOROURACIL | N | N | 300017300 | TRIAL |
| 300006568 | 300004671 | 1.68 | 52.3 | Neo-adjuvant (N) | 2013-07-14 | 2013-07-14 | Trial Unspecified | Y | null | 300017305 | CARBOPLATIN |
| 300006569 | 300004672 | 1.9 | 72.9 | Disease modification (D) | 2012-12-08 | 2013-05-02 | Cetuximab 7 day (Cycle 1) | N | N | 300017306 | TRASTUZUMAB |
| 300006570 | 300004672 | 1.8 | 139 | null | 2017-11-02 | 2017-11-04 | Trial Unspecified | N | null | 300017306 | CISPLATIN + DOCETAXEL |
| 300006571 | 300006935 | 1.72 | 99.7 | Palliative (P) | 2013-12-19 | 2014-05-26 | CARBOPLATIN + RT | 2 | N | 300017312 | CARBOPLATIN |
| 300006572 | 300004674 | 1.56 | 47.4 | Neo-adjuvant (N) | 2015-11-29 | 2015-12-31 | DE-ESCALATE TRIAL | N | null | 300017327 | FLUOROURACIL + MITOMYCIN |
| 300006573 | 300004675 | 1.82 | 65.1 | Curative (C) | 2015-11-21 | 2015-12-08 | Cisplatin 7 day | 02 | Y | 300017340 | GEMCARBO |
| 300006574 | 300004676 | 1.6 | 95.6 | Palliative (P) | 2014-09-27 | 2014-10-09 | GemCarbo Days 1+8 | 2 | N | 300017349 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300006575 | 300004677 | 1.66 | 57.4 | Neo-adjuvant (N) | 2013-03-19 | 2013-04-12 | Oxaliplatin + Modified de Gramont | 2 | N | 300017351 | OXALIPLATIN + MDG |
| 300006576 | 300004678 | null | 117 | Curative (C) | null | 2013-08-31 | Cisplatin | N | Y | 300017353 | CISPLATIN |
| 300006577 | 300004680 | 1.74 | 85.7 | Curative (C) | 2014-06-30 | 2014-07-30 | PACLITAXEL | N | null | 300017359 | CAPECITABINE + OXALIPLATIN |
| 300006578 | 300004682 | 1.53 | 54 | Neo-adjuvant (N) | 2016-01-11 | 2016-02-29 | Trial Unspecified | N | N | 300017362 | CAPECITABINE |
| 300006579 | 300004683 | null | 19.5 | Not known (9) | 2014-08-31 | 2014-09-08 | GEMCARBO | N | N | 300017380 | OXALIPLATIN + MDG |
| 300006580 | 300007777 | 1.73 | 65.9 | Palliative (P) | 2013-05-30 | 2013-05-31 | Trial Unspecified | N | N | 300017380 | GEFITINIB |
| 300006581 | 300004684 | 1.73 | null | null | 2014-10-26 | 2015-02-01 | Cisplatin | N | Y | 300017393 | CARBOPLATIN |
| 300006582 | 300004686 | 1.64 | 59.4 | Palliative (P) | 2017-12-01 | 2018-07-13 | FLUOROURACIL + OXALIPLATIN | N | N | 300017397 | CARBOPLATIN + DOCETAXEL + FLUOROURACIL |
| 300006583 | 300004688 | 1.64 | 74.8 | Neo-adjuvant (N) | null | 2017-12-26 | DE-ESCALATE TRIAL | null | null | 300017403 | TRIAL |
| 300006584 | 300004689 | 1.52 | 3.7 | Palliative (P) | 2015-04-18 | 2015-05-17 | CAPECITABINE + OXALIPLATIN | 02 | N | 300017403 | EOX |
| 300006585 | 300004689 | 1.52 | 57 | Palliative (P) | 2013-08-29 | 2013-11-11 | CISPLATIN + VINORELBINE + RT | Y | N | 300017403 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300006586 | 300004690 | 1.65 | 75.8 | Palliative (P) | 2014-06-03 | 2014-07-20 | Carboplatin + Cetux + FU (>Cycle 2) | 01 | N | 300017416 | CAPECITABINE |
| 300006587 | 300006941 | 1.79 | null | Neo-adjuvant (N) | 2014-10-12 | 2014-10-12 | CARBOPLATIN + RT | N | N | 300017426 | CAPECITABINE + OXALIPLATIN |
| 300006588 | 300004693 | 1.83 | 72 | Neo-adjuvant (N) | 2013-07-20 | 2013-09-14 | Trial Unspecified | Y | N | 300017430 | OXALIPLATIN + MDG |
| 300006589 | 300004694 | 1.6 | 60 | Curative (C) | 2016-07-01 | 2016-08-02 | Cetuximab 7 day (>Cycle 2) | 02 | Y | 300017442 | CARBOPLATIN |
| 300006590 | 300004695 | 1.79 | 106 | Curative (C) | null | 2015-09-16 | CETUXIMAB | N | N | 300017445 | CAPECITABINE + GEMCITABINE |
| 300006591 | 300004695 | 1.7 | 70.8 | Curative (C) | 2016-06-29 | 2016-07-14 | Cetuximab 7 day (>Cycle 2) | N | Y | 300017445 | CETUXIMAB |
| 300006592 | 300004695 | 1.59 | 91.5 | Curative (C) | 2014-10-11 | 2014-12-10 | Cisplatin | 02 | Y | 300017445 | CARBOPLATIN |
| 300006593 | 300004696 | 1.6 | 56.8 | Neo-adjuvant (N) | 2014-05-30 | 2014-08-11 | ETOPOSIDE | N | N | 300017468 | CISPLATIN + FLUOROURACIL |